Bio-Rad Laboratories Profit Margin

The latest profit margin for BIO is 8.59% as of June 2026. That compares with 9.99% in the prior-year period — down 14.0% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Bio-Rad Laboratories's historical trend and sector peers before judging valuation or financial health.

Over the past year, BIO's profit margin moved from 9.99% to 8.59% — a 14.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bio-Rad Laboratories's valuation or profitability profile.

Against Healthcare companies, BIO currently prints 8.59% for profit margin, while the sector average sits near 21.34%. That is roughly 59.7% below the sector mean. Large gaps often invite a closer look at Bio-Rad Laboratories's growth, margins, and balance sheet.

Profit Margin shows how effectively Bio-Rad Laboratories converts resources into returns. At 8.59%, BIO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 9.99% in the prior-year period — down 14.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BIO's profit margin (8.59%), review year-over-year change from 9.99%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.